Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

01-Apr-22 - 30-Mar-23
Buy Ratio:37%


# Net Buyers:32
# Net Sellers:55

Previous 52 Weeks

02-Apr-21 - 31-Mar-22
Buy Ratio:33%
# Net Buyers:82
# Net Sellers:168
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Regeneron Pharmaceuticals, Inc.($123.32K)$898.67M  
Eli Lilly & Co--$820.11M  
Catalent, Inc.($977.74K)$420.69M  
Innoviva, Inc.--$391.86M  
Chemocentryx, Inc.--$161.63M  
New Net Buyers
CompanyNet Buy AmountChange
Merck & Co., Inc.$1.54M$89.00M  
Chinook Therapeutics, Inc.$8.05M$62.72M  
Immunitybio, Inc.$56.63M$59.38M  
Alkermes Plc.$815.73K$18.88M  
Neurocrine Biosciences Inc$545.95K$7.83M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Kindred Biosciences, Inc.--($398.20M)  
Incyte Corp$7.74M($99.09M)  
Armata Pharmaceuticals, Inc.--($49.00M)  
MacRogenics Inc--($25.10M)  
Molecular Templates, Inc.--($20.71M)  
New Net Sellers
CompanyNet Buy AmountChange
Karyopharm Therapeutics Inc.($3.47M)($3.69M)  
Bausch Health Companies Inc.($35.39K)($2.31M)  
Galectin Therapeutics Inc($116.48K)($369.11K)  
Sarepta Therapeutics, Inc.($3.92K)($273.66K)  
Intercept Pharmaceuticals, Inc.($107.46K)($143.02K)